Generated by AI
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and metabolic disease, infectious disease, hematology, and rare disorders. The company is known for combining laboratory research, clinical development, and in-house manufacturing to advance biologic therapies and antibody-based medicines. Regeneron also works on product candidates across multiple therapeutic areas, supporting a broad drug pipeline alongside its marketed medicines. Regeneron Pharmaceuticals, Inc. plays an important role in the healthcare market through its focus on specialty therapies designed for complex and often chronic medical conditions.
Website777 Old Saw Mill River Road
Tarrytown, NY, 10591-6707
United States
The latest articles about REGN.
Summary of Nov 17's posts. Generated by AI.
Summary of Nov 2's posts. Generated by AI.
Summary of May 18's posts. Generated by AI.
Summary of Nov 3's posts. Generated by AI.
Investors talking about REGN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.